Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gluten in pharmaceutical products

J P Crowe1, N P Falini

  • 1Camilla Hall Nursing Home, P.O. Box 100, King and Frazer Roads, Immaculata, PA 19345-0100, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|March 22, 2001
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy.

BJS open·2019
Same author

Primary gynecological neoplasms and clinical outcomes in patients diagnosed with breast carcinoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006
Same author

Tumour-derived mutated K-ras codon 12 expression in regional lymph nodes of stage II colorectal cancer patients is not associated with increased risk of cancer-related death.

International journal of colorectal disease·2001
Same author

Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer.

The British journal of surgery·1999
Same author

Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ.

Journal of the American College of Surgeons·1999
Same author

Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group.

Alimentary pharmacology & therapeutics·1999